ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $190.31 +0.99%
Revenue Growth %: +13.1%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +13.1%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- B.C. households cutting back on groceries and essentials as cost-of-living crisis worsens: new survey
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
